📰 Sam Possemiers News
Sam Possemiers News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sam Possemiers. Real-time updates on events, politics, business and more.
February 20, 2024
MRM Health a clinicalstage biopharmaceutical company announced today that it has received regulatory and ethics committee approval to start an observational crosssectional clinical trial to study the role of the small intestinal microbiome in Parkinsons Disease PD and to identify PDspecific microbial and metabolic fingerprints in small intestinal fluid and blood.
September 19, 2023
MRM Health NV a clinicalstage biopharmaceutical company focused on developing nextgeneration live microbiome consortia therapeutics today reports positive topline results from its Phase 2a clinical trial with MH002 in mildtomoderate Ulcerative Colitis UC.
June 7, 2023
MRM Health a clinical-stage biopharmaceutical company focused on developing innovative microbiome-based biotherapeutics based on its proprietary and unique CORAL® platform technology today announced
March 7, 2023
Completed patient enrollment in its phase 2a trial in Ulcerative Colitis with next- generation live microbiome consortia therapeutic MH002, with topline results expected in Q3 2023. - Has ongoing patient
December 13, 2022
MRM Health-a clinical-stage biopharmaceutical company focused on developing next-generation live microbiome consortia therapeutics-today announced that its Type-2 Diabetes Program, developed in collaboration
June 28, 2022
GHENT, Belgium, June 28, 2022 (GLOBE NEWSWIRE) -- MRM Health, a clinical-stage biopharmaceutical company developing next-generation live microbiome consortia therapeutics, announced today that they have
June 28, 2022
MRM Health has received regulatory approval from the FAMHP in Belgium to start a phase 2 trial for patients with pouchitis.
June 28, 2022
MRM Health Starts Clinical Trial with Next-Generation Optimized Consortium Therapeutic MH002 in Pouchitis GlobeNewswire June 28, 2022 GHENT, Belgium, June 28, 2022 (GLOBE NEWSWIRE) -- MRM Health, a clinical-stage biopharmaceutical company developing next-generation live microbiome consortia therapeutics, announced today that they have received regulatory approval from the Federal Agency for Medicines and...
June 7, 2022
GHENT, Belgium, June 07, 2022 (GLOBE NEWSWIRE) -- MRM Health, a clinical-stage biopharmaceutical company developing next-generation live microbiome consortia therapeutics, announces the publication of
June 7, 2022
Investegate announcements from MRM Health NV, MRM Health Reports Preclinical Results Showing a 9-Strain Bacterial Consortium Delays Non-Alcoholic Fatty Liver Disease Progression and Liver Fibrosis